首页> 美国卫生研究院文献>Scientific Reports >Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats
【2h】

Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats

机译:柴胡-疏肝-散对大鼠抗生素致肠道菌群失调保护作用的尿和粪代谢组学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accumulating evidence suggests that the gut microbiota dysbiosis and their host metabolic phenotype alteration is an important factor in human disease development. A traditional Chinese herbal formula, Chaihu-Shu-Gan-San (CSGS), has been effectively used in the treatment of various gastrointestinal (GI) disorders. The present study was carried out to investigate whether CSGS modulates the host metabolic phenotype under the condition of gut microbiota dysbiosis. The metabonomics studies of biochemical changes in urine and feces of antibiotic-induced gut microbiota dysbiosis rats after treatment with CSGS were performed using UPLC-Q-TOF/MS. Partial least squares-discriminate analysis (PLS-DA) indicated that the CSGS treatment reduced the metabolic phenotype perturbation induced by antibiotic. In addition, there was a strong correlation between gut microbiota genera and urinary and fecal metabolites. Moreover, the correlation analysis and the metabolic pathway analysis (MetPA) identified that three key metabolic pathways including glycine, serine and threonine metabolism, nicotinate and nicotinamide metabolism, and bile acid metabolism were the most relevant pathways involved in antibiotic-induced gut microbiota dysbiosis. These findings provided a comprehensive understanding of the protective effects of CSGS on the host metabolic phenotype of the gut microbiota dysbiosis rats, and further as a new source for drug leads in gut microbiota-targeted disease management.
机译:越来越多的证据表明,肠道菌群失调及其宿主代谢表型的改变是人类疾病发展的重要因素。一种传统的中草药配方,柴胡-疏肝-肝散(CSGS),已被有效地用于治疗各种胃肠道(GI)疾病。本研究旨在研究CSGS是否在肠道菌群失调的情况下调节宿主代谢表型。使用UPLC-Q-TOF / MS进行了CSGS治疗后,抗生素诱导的肠道菌群失调症大鼠尿液和粪便中生化变化的代谢组学研究。偏最小二乘分析(PLS-DA)表明,CSGS处理可降低抗生素引起的代谢表型扰动。此外,肠道菌群属与尿和粪便代谢产物之间也有很强的相关性。此外,相关性分析和代谢途径分析(MetPA)确定了三个关键的代谢途径,包括甘氨酸,丝氨酸和苏氨酸代谢,烟酸和烟酰胺代谢以及胆汁酸代谢,是与抗生素诱导的肠道菌群失调相关的最相关途径。这些发现提供了对CSGS对肠道菌群失调大鼠宿主代谢表型的保护作用的全面理解,并进一步作为针对肠道菌群的疾病治疗药物线索的新来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号